Key Points
1EZ0.BE stock drops 12.24% to €0.248 on Berlin exchange, showing oversold bounce signals.
Europlasma faces severe financial stress with negative cash flow and 99.44% one-year decline.
Meyka AI rates stock B grade with HOLD recommendation and bullish long-term forecasts.
Waste management and plasma technology segments offer growth potential despite near-term execution risks.
Europlasma S.A. (1EZ0.BE) is showing classic oversold bounce signals after a sharp 12.24% decline on the Berlin exchange. The French waste management and plasma technology company trades at €0.248 per share, down from its previous close of €0.2826. Despite the recent selloff, 1EZ0.BE stock has stabilized at support levels, attracting attention from value-focused traders. The company operates four business segments: Plasma Solutions, Hazardous Waste, Decarbonization, and Industries. With 1,501,800 shares outstanding and a market cap of €372,446, this micro-cap industrial stock presents an interesting case study in oversold recovery patterns.
Understanding the Recent Selloff in 1EZ0.BE Stock
Europlasma’s recent decline reflects broader market pressures on micro-cap industrial stocks. The 12.24% single-day drop pushed 1EZ0.BE stock to its day low of €0.248, matching the opening price. Over longer timeframes, the damage is more severe: the stock has fallen 99.44% over one year and 98.68% over six months, indicating a prolonged downtrend.
However, the current price sits above the 52-week low of €0.224, suggesting some buyers are stepping in. The 50-day moving average stands at €0.334, while the 200-day average is €12.851, showing how far the stock has compressed. Track 1EZ0.BE on Meyka for real-time price updates and technical signals.
Market Sentiment and Trading Activity
Trading volume remains thin, with average daily volume at just 58 shares. This illiquidity explains the sharp price swings and makes 1EZ0.BE stock vulnerable to sudden moves. The Money Flow Index (MFI) sits at 50.00, indicating neutral momentum without clear directional bias.
Liquidation pressures appear to have eased, as the stock found a floor near €0.248. The Relative Vigor Index (RVI) also reads 50.00, suggesting neither buyers nor sellers have overwhelming control. For a micro-cap waste management stock, these neutral technical readings often precede consolidation or recovery phases.
Financial Metrics and Valuation Reality
Europlasma’s financial picture is challenging. The company shows negative earnings with a net profit margin of -74.38% and negative free cash flow of -€97.47 per share. The price-to-sales ratio of 0.0062 appears cheap, but this reflects the stock’s distressed valuation rather than opportunity.
Key metrics reveal operational stress: working capital is negative at -€13.48 million, and the current ratio of 0.80 indicates liquidity concerns. However, the company maintains €37.56 per share in cash, providing a buffer. Revenue per share reaches €215.38, showing the business still generates sales despite profitability challenges.
Meyka AI Grade and Forward Outlook
Meyka AI rates 1EZ0.BE with a grade of B, suggesting a HOLD recommendation with a score of 64.53. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Meyka AI’s forecast model projects 1EZ0.BE stock could reach €501.01 within one year, implying massive upside from current levels. However, forecasts are model-based projections and not guarantees. The five-year forecast of €2,034.62 reflects optimism about the company’s plasma technology and decarbonization segments, though execution risk remains high.
Final Thoughts
Europlasma (1EZ0.BE) presents a classic oversold bounce setup for contrarian traders, though significant risks remain. The stock’s 12% decline has pushed it to support levels, with neutral technical indicators suggesting consolidation. The company’s waste management and plasma technology segments operate in growing markets, but negative cash flow and liquidity concerns demand caution. Meyka AI’s B grade and bullish long-term forecasts reflect potential recovery, yet the stock’s catastrophic one-year performance (-99.44%) underscores execution challenges. Investors should monitor quarterly earnings and cash burn rates closely before committing capital to this micro-cap industrial play.
FAQs
The decline reflects pressure on micro-cap industrial stocks. Europlasma’s negative cash flow and liquidity challenges likely drove selling pressure on the Berlin exchange.
Meyka AI rates it HOLD with a B grade. While technically oversold, negative earnings and cash flow present real risks. Review quarterly results before investing.
Europlasma operates four segments: Plasma Solutions, Hazardous Waste, Decarbonization, and Industries. The company generates €215.38 revenue per share despite profitability challenges.
Meyka AI projects €501.01 within one year and €2,034.62 within five years. These are model-based projections with execution risk from negative cash flow.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)